Ilja Spellmann

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

Norbert Müller, Markus Schwarz, Sandra Dehning et al. · Molecular Psychiatry · 2006 · 795 citations

Medicine, Pharmacology, Psychiatry +17

Risperidone plasma levels, clinical response and side–effects

Michael Riedel, Markus Schwarz, Martin Strassnig et al. · European Archives of Psychiatry and Clinical Neuroscience · 2004 · 140 citations

Medicine, Pharmacology, Pharmacotherapy +12

Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression — No influence of celecoxib treatment

Richard Musil, Markus Schwarz, Michael Riedel et al. · Journal of Affective Disorders · 2011 · 126 citations

Medicine, Pharmacology, Psychiatry +17

IL-2 and IL-4 polymorphisms as candidate genes in schizophrenia

Markus Schwarz, Holger Krönig, Michael Riedel et al. · European Archives of Psychiatry and Clinical Neuroscience · 2005 · 81 citations

Life Sciences, Genetics, Molecular Genetics +14

Quetiapine in the treatment of schizophrenia and related disorders

Michael Riedel, Norbert Müller, Martin Strassnig et al. · Neuropsychiatric Disease and Treatment · 2007 · 78 citations

Medicine, Pharmacology, Psychiatry +17